167 related articles for article (PubMed ID: 15326317)
1. Human subjects research. Pediatric study of ADHD drug draws high-level public review.
Couzin J
Science; 2004 Aug; 305(5687):1088-9. PubMed ID: 15326317
[No Abstract] [Full Text] [Related]
2. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
't Jong GW; van den Anker JN
Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
[No Abstract] [Full Text] [Related]
3. Institutional review boards (IRBs) and risk considerations for children.
Maloney DM
Hum Res Rep; 2004 Sep; 19(9):1-3. PubMed ID: 15675081
[No Abstract] [Full Text] [Related]
4. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
Solanto MV
Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
[No Abstract] [Full Text] [Related]
5. Children in clinical research: a conflict of moral values.
Sharav VH
Am J Bioeth; 2003; 3(1):W-IF 2. PubMed ID: 14560714
[TBL] [Abstract][Full Text] [Related]
6. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
[TBL] [Abstract][Full Text] [Related]
7. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
8. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA
Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
[TBL] [Abstract][Full Text] [Related]
9. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach.
DeSantis AD; Webb EM; Noar SM
J Am Coll Health; 2008; 57(3):315-24. PubMed ID: 18980888
[TBL] [Abstract][Full Text] [Related]
10. Preschool meds: the first clinical trial examining the effects of generic Ritalin on 3- to 5-year-old subjects raises questions not only about the safety of the drug but also about the ethics of testing on ever younger brains.
Stolberg SG
N Y Times Mag; 2002 Nov; ():58-61. PubMed ID: 17080573
[No Abstract] [Full Text] [Related]
11. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
Staller JA; Faraone SV
Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
[TBL] [Abstract][Full Text] [Related]
12. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
13. Drug development process for a product with a primary pediatric indication.
Allen AJ; Michelson D
J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
[TBL] [Abstract][Full Text] [Related]
14. Lisdexamfetamine dimesylate.
Elia J; Easley C; Kirkpatrick P
Nat Rev Drug Discov; 2007 May; 6(5):343-4. PubMed ID: 17539056
[No Abstract] [Full Text] [Related]
15. Ritalin is okay for kids with both ADHD and Tourette's syndrome, study says.
Levenson D
Rep Med Guidel Outcomes Res; 2002 Mar; 13(6):5-7. PubMed ID: 12449103
[No Abstract] [Full Text] [Related]
16. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
[TBL] [Abstract][Full Text] [Related]
17. Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling.
Rowe DL; Robinson PA; Gordon E
Clin Neurophysiol; 2005 Feb; 116(2):324-35. PubMed ID: 15661111
[TBL] [Abstract][Full Text] [Related]
18. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
[No Abstract] [Full Text] [Related]
19. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
20. A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
Cornell S
Adv Nurse Pract; 2000 Dec; 8(12):62-4. PubMed ID: 12397912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
